Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04226092 · ClinicalTrials.gov registry record · NA
Pre-SunBeam TEWL AUC
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT04226092 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 33 participants.
The verdict
NCT04226092, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Transepidermal Water Loss (TEWL) measurements are a valuable tool to determine the integrity of a person's skin barrier. In patients with skin conditions, like atopic dermatitis, skin barrier can be disrupted or weakened, leading to a more severe phenotype and disease characteristics. There are several commercially available TEWL measuring devices, including the Aquaflux AF200 and the GPSkin Barrier Pro. This study is a pilot study to determine if these two devices produce similar readings for TEWL/skin barrier on patients with and without atopic dematitis (AD). The research team would like to investigate whether these devices are comparable for initial TEWL readings as well as after several rounds of tape strips have been collected from the skin. Tape strips are small circular adhesives, much like tape, that remove the very outermost layers of skin cells. It will be important to know if both of these devices provide correlative values for TEWL once the outermost layers of the skin have been removed by tape stripping.
Interventions
- DEVICE GPSkin Barrier Pro
- DEVICE Aquaflux AF200
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-11-07 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04226092
The ClinicalTrials.gov registry entry for NCT04226092 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GPSkin Barrier Pro is the first listed.
NCT04226092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04226092 about?
NCT04226092 is a clinical study titled "Pre-SunBeam TEWL AUC". Transepidermal Water Loss (TEWL) measurements are a valuable tool to determine the integrity of a person's skin barrier. In patients with skin conditions, like atopic dermatitis, skin barrier can be disrupted or weakened, leading to a more severe phenotype and disease characteristics. There are seve...
What is the current status of trial NCT04226092?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-11-07. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT04226092?
The interventions under investigation include: GPSkin Barrier Pro (DEVICE), Aquaflux AF200 (DEVICE).
Who is sponsoring clinical trial NCT04226092?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.